PM Modi to visit Serum Institute on November 28

Published On 2020-11-27 06:11 GMT   |   Update On 2020-11-27 06:11 GMT

Pune: Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the Oxford University for Covid-19 vaccine, a senior official said on Thursday.The Central Drug Standard Control Organisation has granted permission for manufacture of Covid-19 vaccine for pre-clinical test, examination and analysis...

Login or Register to read the full article

Pune: Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the Oxford University for Covid-19 vaccine, a senior official said on Thursday.

The Central Drug Standard Control Organisation has granted permission for manufacture of Covid-19 vaccine for pre-clinical test, examination and analysis to seven firms, two of which are the Serum Institute of India (SII) and the Gennova Biopharmaceuticals.
"We have received a confirmation about PM Modi's visit to the Serum Institute of India on Saturday, but his minute-to -minute program is yet to be received," Pune Divisional Commissioner Saurabh Rao said.
On Tuesday, Rao said there was a possibility of the PM's visit to Pune, and if that happens, it would be aimed at reviewing the status of the vaccine candidate for coronavirus infection and to know about its launch, production and distribution mechanisms.
Rao had also informed that ambassadors and envoys from 100 countries will visit the Serum Institute of India and the Gennova Biopharmaceuticals Ltd here on December 4.

Read also: Oxford COVID vaccine shows average efficacy of 70 percent: AstraZeneca



Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News